Russ Berrie Medical Science Pavilion
New York, 10032, United States
NCT Number: NCT05139264
GLADS is a cross-sectional, observational study assessing free-living diet, physical activity, sleep, and glucose profile over a 2-week period in healthy adult men and women.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
New York, 10032, United States
Monitoring free-living lifestyle behaviors can provide important information on behavioral determinants of health. New technologies have improved accessibility of ambulatory assessment of diet, biomarkers, physical activity, and sleep. The study will assess the effects of free-living diet assessed by questionnaire and sleep and physical activity measured by actigraphy on interstitial glucose measured by continuous glucose monitoring in healthy adult men and women over a 2-week period.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observation of diet, physical activity, sleep and interstitial glucose
Time frame: 2 weeks
Mean, fasting, post-prandial measured by continuous glucose monitoring
Time frame: 2 weeks
Measured by actigraphy
Time frame: 2 weeks
Measured by actigraphy
Time frame: 2 weeks
Carbohydrates, fats, proteins assessed by dietary recall
Columbia University
Other
GLADS Study: Glucose, Activity, Diet, & Sleep Assessment Study
Acronym: GLADS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05238012
Diabetes Mellitus, Dyslipidemias
Beijing, Beijing Municipality, China
View Trial DetailsNCT06288126
Glucose Metabolism Disorders, Hyperinsulinism
Pisa, Italy
View Trial DetailsNCT05968235
Glucose Metabolism Disorders, Hypopigmentation
Xi'an, Shaanxi, China
View Trial DetailsNCT03162991
Behavior, Glucose Metabolism Disorders
Columbia, South Carolina, United States
View Trial Details